Summary: Review of the principles for making peptide based-FSL constructs
Henry SM, Komarraju S, Heathcote D, Rodinov I. Designing peptide-based FSL constructs to create Miltenberger kodecytes. ISBT Science Series (2011); 6(2): 306-312
Category: 2011
Summary: Toronto University show prevention of HIV infection of cells with FSL-GB3
Harrison AL, Henry S, Mahfoud R, Manis A, Albertini A, Gaudin Y, Lingwood CA, and Branch DR. A novel VSV/HIV pseudotype approach for the study of HIV microbicides without requirement for level 3 biocontainment. Future Virology (2011); 6(10): 1241-1259
Summary: Mayo Clinic shows FSL-fluorescent and FSL-radiolabeling of virus and bioimaging of labeled virus in mice
Hadac EM, Federspiel MJ, Chernyy E, Tuzikov A, Korchagina E, Bovin NV, Russell S, Henry SM. Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. J Virological Methods (2011); 176(1-2): 78-84
Summary: Video and protocol showing generic use of Kode™ Technology – sponsored by Sigma-Aldrich
Blake DA, Bovin NV, Bess D, Henry SM. FSL Constructs: A Simple Method for Modifying Cell/Virion Surfaces with a Range of Biological Markers Without Affecting their Viability. J Visualized Experiments (2011) Aug 5; (54): e3289
Summary: Flow cytometry of kodecytes made to mimic antigen strengths of ABO cells with weak antigen expression
Hult AK, Frame T, Chesla S, Henry S, Olsson ML. Flow cytometry evaluation of red blood cells mimicking naturally-occurring ABO subgroups following modification with variable amounts of function-spacer-lipid A and B constructs. Transfusion (2011); 52(2): 247-251
Summary: FSL-CMV peptides were used to create an assay for determining Fc functionality of IgG prepared for in intravenous infusion
Georgakopoulos T, Komarraju S, Henry S, Bertolini J. An improved Fc function assay utilising CMV antigen-coated red blood cells generated with synthetic Function-Spacer-Lipid constructs. Vox Sanguinis (2012); 102(1): 72-78
Summary: Circulating antibodies were neutralised with FSLs allowing for incompatible transfusion in mice
Oliver C, Blake D, Henry S. In vivo neutralization of anti-A and successful transfusion of A antigen-incompatible red cells in an animal model. Transfusion (2011); 51(12): 2664-2675
Summary: Independent validation of Kode™ Miltenberger product
V. S. Nadarajan, A. A. Laing, S. M. Saad & M. Usin. Prevalence and specificity of red-blood-cell antibodies in a multiethnic South and East Asian patient population and influence of using novel MUT+Mur+ kodecytes on its detection. Vox Sang. (2011) Jan;102(1):65-71.
Summary: FSL biotin labeled red cells can be used to determine in vivo cell survival and allow for retrieval of cells from the circulation
Oliver C, Blake D, Henry S. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes. Transfusion (2011); 51(8): 1723-1730